Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -3084.76% is 411% below its 5-year average of -603.52%, near the high end of its 5-year range (-12857.05%–0.00%).
1232.38% below its 12-month average of -231.52%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
-3084.76%
OPERATING MARGIN AVG TTM
-231.52%
OPERATING MARGIN AVG 3Y
-990.11%
OPERATING MARGIN AVG 5Y
-603.52%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-1232.38%
CURRENT VS 3Y AVG
-211.56%
CURRENT VS 5Y AVG
-411.13%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 558 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Immunome, Inc.
Market Cap
$1.99B
Operating Margin
-3084.76%
TTM Avg
-231.52%
3Y Avg
-990.11%
5Y Avg
-603.52%
Market Cap
$2.00B
Operating Margin
-5.12%
TTM Avg
-2.62%
3Y Avg
-10.04%
5Y Avg
-13.46%
Market Cap
$2.01B
Operating Margin
37.06%
TTM Avg
17.54%
3Y Avg
-25.09%
5Y Avg
-117.46%
Market Cap
$2.02B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.95B
Operating Margin
-18.48%
TTM Avg
-24.30%
3Y Avg
-28.12%
5Y Avg
-27.55%
Market Cap
$2.04B
Operating Margin
38.98%
TTM Avg
19.21%
3Y Avg
-11.92%
5Y Avg
-190.31%
Market Cap
$2.02B
Operating Margin
6.02%
TTM Avg
5.04%
3Y Avg
-2.01%
5Y Avg
-12.30%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immunome, Inc. (IMNM) | $1.99B | -3084.76% | -231.52% | -990.11% | -603.52% |
| AxoGen, Inc. (AXGN)vs › | $2.00B | -5.12% | -2.62% | -10.04% | -13.46% |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.01B | 37.06% | 17.54% | -25.09% | -117.46% |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $2.02B | 0.00% | 0.00% | 0.00% | 0.00% |
| Azenta, Inc. (AZTA)vs › | $2.03B | -3.49% | -3.57% | -5.95% | -5.03% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.95B | -18.48% | -24.30% | -28.12% | -27.55% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.04B | 38.98% | 19.21% | -11.92% | -190.31% |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.02B | 6.02% | 5.04% | -2.01% | -12.30% |
| Alvotech (ALVO)vs › | $2.07B | 9.62% | 13.78% | -194.45% | -270.76% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | -1.12% | -4.89% | -11.52% | -13.12% |
Gross Margin
57.4%
Operating Margin
-3084.8%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | -1157.61% |
| 2025-03-31 | -1525.50% |
| 2024-12-31 | -3030.31% |
| 2024-09-30 | -1736.15% |
| 2024-06-30 | -1692.43% |
| 2024-03-31 | -12857.05% |
| 2023-12-31 | -2473.94% |
| 2023-09-30 | -129.96% |
| 2023-06-30 | -135.42% |
| 2023-03-31 | -189.13% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
